Immunization with DNA Vaccine Elicits Specific Immune Response Against Hepatitis C Virus

Immunization with a DNA vaccine encoding the hepatitis C virus structural antigens elicits a specific immune response against the capsid and envelope proteins in rabbits and crab-eating macaque monkeys. Scientists evaluating the capability of the plasmid pIDKE2, encoding the HCV structural proteins Core, E1, and E2, found that it induced immune response against HCV antigens in animal models. The study, published in the journal Biotechnology and Applied Biochemistry, demonstrates the potential of the DNA vaccine in eliciting both humoral and cellular immunity against HCV structural antigens.

Key Takeaways:

  • The study evaluated the capability of the plasmid pIDKE2 to induce immune response against HCV antigens in rabbits and Macaca irus (crab-eating macaque).
  • All rabbits immunized with pIDKE2 generated a positive antibody response, with antibody titers reaching values above 1:1500 and 1:400 against the core and the envelope proteins, respectively, 28 weeks after primary immunization.
  • The antibody response in monkeys developed slowly, but antibody titers greater than 1:3500 against HCV structural antigens were detected at week 52.
  • Anti-E2 antibodies recognized synthetic peptides covering the HVR-1 (hypervariable region-1) from different isolates corresponding to different genotypes.
  • A specific lymphoproliferative response against Core and E2 was detected in two out of three monkeys immunized with pIDKE2.
  • The study demonstrates the potential of the DNA vaccine in eliciting both humoral and cellular immunity against HCV structural antigens in animal models.

Statistics:

  • 28 weeks: Time period after primary immunization when antibody titers reached values above 1:1500 and 1:400 against the core and the envelope proteins, respectively, in rabbits immunized with 2 mg of plasmid pIDKE2.
  • Week 52: Time point when antibody titers greater than 1:3500 against HCV structural antigens were detected in monkeys immunized with pIDKE2.
  • 1:1500 and 1:400: Antibody titers against the core and the envelope proteins, respectively, in rabbits immunized with 2 mg of plasmid pIDKE2.
  • 1:3500: Antibody titers against HCV structural antigens in monkeys immunized with pIDKE2 at week 52.

Sources:

  • Duenas-Carrera, Santiago, et al. "Immunization with a DNA vaccine encoding the hepatitis-C virus structural antigens elicits a specific immune response against the capsid and envelope proteins in rabbits and Macaca irus (Crab-eating macaque monkeys)." Biotechnol Appl Biochem, vol. 39, no. Part 2, 2004, pp. 249-255.
  • Centro de Ingenieria Genetica y Biotecnologia, Cuba. "Immunization with a DNA vaccine encoding the hepatitis-C virus structural antigens elicits a specific immune response against the capsid and envelope proteins in rabbits and Macaca irus (Crab-eating macaque monkeys)." Biotechnol Appl Biochem, vol. 39, no. Part 2, 2004, pp. 249-255.
  • Health & Medicine Week. "Immunization with a DNA vaccine encoding the hepatitis-C virus structural antigens elicits a specific immune response against the capsid and envelope proteins in rabbits and Macaca irus (Crab-eating macaque monkeys)."